The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D002991:Clofazimine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003248:Constipation / Q000139:chemically induced; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004415:Dyspepsia / Q000139:chemically induced; D004906:Erythrocyte Count; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007918:Leprosy / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology / Q000652:urine; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000302:isolation & purification; D012871:Skin Diseases / Q000139:chemically induced; D013450:Sulfones / Q000627:therapeutic use
D013450:Sulfones; D002991:Clofazimine